For over 45 years, we’ve been excelling at generic R&D and production,
giving our customers timely and responsive support in an agile, flexible, and
reliable manner, fulfilling your every need and expectation.
This is how we do business, and this is how we succeed.
Unipharm’s entire team is dedicated to fulfilling our customers’ needs and expectations. Our entrepreneurial culture enables us to act fast and to respond to our customers’ needs in an agile, reliable manner. It all begins with the thorough planning of each and every project, ensuring its execution within the given timeline.
Every out-licensing project is accompanied by a responsive team, a quick yet tailored resolution to any issue along the way, and swift Management decision making. By providing all of these, we grant our customers all of the support needed to ensure a swift registration process, leading to a successful launch.
While many companies withdraw tail products from the market, especially of generics whose sales have declined, Unipharm continues to market its entire product portfolio in Israel.
For some of our products, only few manufacturers remain worldwide. We continue to offer a broad range of niche generics, presenting unique and interesting opportunities for our customers around the globe.
Our dedication to our customers also manifests itself in our inherent ability to shorten delivery times, provide quantities beyond the predicted forecast, and respond to specific customer requests.
We make ourselves available at any time of the day and will go out of our way to make sure you get exactly what you need.
Unipharm’s large generic portfolio includes drug products from a broad range of therapeutic areas: cardiovascular, central nervous system, anti-infectives, men’s health, and more.SEE ALL therapeutic areas